Evidence map›Paper›PMID 40558591›Full record

ReviewDiseases (Basel, Switzerland)2025

Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes.

Chiara Anna Fiasconaro, Alice Carbone, Silvia Giordano, Francesco Cavallo, Paolo Fava, Barbara Pasini, Yuliya Yakymiv, Sara Marchisio, Pietro Quaglino, Simone Ribero and 1 more

Abstract readReview
In one paragraph

Review in Diseases (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chiara Anna FiasconaroDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Alice CarboneDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Silvia GiordanoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Francesco CavalloDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-9296-826X
Paolo FavaDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-8443-7458
Barbara PasiniMedical Genetics Unit, AOU 'Città Della Salute e Della Scienza', 'Molinette' Hospital, 10126 Turin, Italy.ORCID 0000-0002-4373-1212
Yuliya YakymivLaboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-9598-3462
Sara MarchisioLaboratory of Immunogenetics, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7005-837X
Pietro QuaglinoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.
Simone RiberoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0098-1406
Gabriele RoccuzzoDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7126-5506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiology of melanoma is multifactorial and arises from the interplay of genetic, phenotypic, and environmental factors. The genetic predisposition to melanoma is influenced by a complex interaction among genes exhibiting varying levels of penetrance (high, moderate, and low), each contributing differently to the susceptibility of the disease. Furthermore, penetrance may vary based on the incidence of melanoma across diverse populations and geographical regions. Advances in genetic sequencing technologies have facilitated the identification of novel genes potentially associated with melanoma, as well as the characterization of relevant germline variants. While the most extensively researched variant is CDKN2A, recent studies have highlighted other variants unrelated to CDKN2A as significant areas of investigation. Among them, high-penetrance genes encompass CDK4, BAP1, POT1, TERT, ACD, and TERF2IP. In contrast, moderate-penetrance genes include MC1R, MITF, and SLC45A2, while low-penetrance genes consist of OCA2, TYRP1, and TYR. In addition to elevating the risk of melanoma, these genetic alterations may also predispose individuals to internal neoplasms. This review aims to provide a comprehensive overview of the definitions of sporadic, multiple primary, familial, and hereditary melanoma, with a particular emphasis on non-CDKN2A germline variants and their dermoscopic and phenotypic features.

Indexed as

genesgenetic testgermline varianthereditary cancer syndromeshereditary melanomamelanomatumor associations

Identifiers

PMID40558591
PMCPMC12191738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.